IHP supported research on drug policy and value in 2024
The following research supported by the Kaiser Permanente Institute for Health Policy was published in 2024: Tibau A, Hwang TJ, Avorn J, Kesselheim AS. Clinical value of guideline recommended molecular targets and genome targeted cancer therapies: cross sectional study. BMJ…